Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
about
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Preclinical Evidence That 5-HT ...... Psychostimulant Use Disorders.
@en
type
label
Preclinical Evidence That 5-HT ...... Psychostimulant Use Disorders.
@en
prefLabel
Preclinical Evidence That 5-HT ...... Psychostimulant Use Disorders.
@en
P2093
P2860
P356
P1476
Preclinical Evidence That 5-HT ...... Psychostimulant Use Disorders.
@en
P2093
Austin R Cotter
Janet L Neisewander
Kenneth Leslie
Raul Garcia
P2860
P304
P356
10.1093/IJNP/PYX025
P577
2017-04-22T00:00:00Z